Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3875615rdf:typepubmed:Citationlld:pubmed
pubmed-article:3875615lifeskim:mentionsumls-concept:C0030350lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C0010055lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:3875615lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:3875615pubmed:issue5lld:pubmed
pubmed-article:3875615pubmed:dateCreated1985-10-8lld:pubmed
pubmed-article:3875615pubmed:abstractTextDuring coronary artery bypass surgery graft flows were measured. The measurements were made after cardiopulmonary bypass had been discontinued. The recordings were made over a ten year period and a total of 1,151 grafts in 720 patients are included. Except where the flow down a graft was large, 20 mg of Papaverine were injected into the graft and this usually resulted in the flow increasing by at least 100%. A satisfactory response was not achieved in 32 of the 538 grafts in which Papaverine was injected but subsequent probing of the distal anastomosis achieved a markedly improved flow in 80%.lld:pubmed
pubmed-article:3875615pubmed:languageenglld:pubmed
pubmed-article:3875615pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875615pubmed:citationSubsetIMlld:pubmed
pubmed-article:3875615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3875615pubmed:statusMEDLINElld:pubmed
pubmed-article:3875615pubmed:issn0021-9509lld:pubmed
pubmed-article:3875615pubmed:authorpubmed-author:LewisBBlld:pubmed
pubmed-article:3875615pubmed:authorpubmed-author:MonroJ LJLlld:pubmed
pubmed-article:3875615pubmed:authorpubmed-author:FoxworthyJ...lld:pubmed
pubmed-article:3875615pubmed:issnTypePrintlld:pubmed
pubmed-article:3875615pubmed:volume26lld:pubmed
pubmed-article:3875615pubmed:ownerNLMlld:pubmed
pubmed-article:3875615pubmed:authorsCompleteYlld:pubmed
pubmed-article:3875615pubmed:pagination439-42lld:pubmed
pubmed-article:3875615pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:3875615pubmed:meshHeadingpubmed-meshheading:3875615-...lld:pubmed
pubmed-article:3875615pubmed:meshHeadingpubmed-meshheading:3875615-...lld:pubmed
pubmed-article:3875615pubmed:meshHeadingpubmed-meshheading:3875615-...lld:pubmed
pubmed-article:3875615pubmed:meshHeadingpubmed-meshheading:3875615-...lld:pubmed
pubmed-article:3875615pubmed:articleTitleThe response to papaverine in coronary artery bypass graft flows.lld:pubmed
pubmed-article:3875615pubmed:publicationTypeJournal Articlelld:pubmed